Sanofi, GSK announce start of phase 1/2 of joint COVID-19 vaccine

Sanofi, GSK announce start of phase 1/2 of joint COVID-19 vaccine
# 03 September 2020 10:44 (UTC +04:00)

Two multinational pharmaceutical companies, France's Sanofi and UK's GSK, on Thursday announced the start of the Phase 1/2 clinical trial for their jointly developed COVID-19 vaccine, APA reports citing Sputnik.

"Following encouraging pre-clinical study results, today Sanofi and GSK announce the start of the Phase 1/2 clinical trial for our COVID19 vaccine," Sanofi said on Twitter.

#
#

THE OPERATION IS BEING PERFORMED